Fragility fractures of the hip have a major impact on the lives of patients and their families. This study highlights significant geographical variation in secondary fracture prevention with even the highest performing regions failing the majority of patients despite robust evidence supporting the benefits of diagnosis and treatment. CONCLUSIONS: Significant geographic differences exist in prescribing of anti-osteoporosis drugs after hip fracture despite adjustment for potential confounders. Further work examining differences in health care provision may inform strategies to improve secondary fracture prevention after hip fracture.Watch Full Movie Online Streaming Online and Download
Shah A, Prieto-Alhambra D, Hawley S, Delmestri A, Lippett j,Cooper C, Judge A, Javaid MK; REFReSH study team.
